Come join us next week, for an exciting series of keynote speakers and bespoke workshops discussing many subjects under the theme of research integrity.
We start the week of events with a talk by James Parry, Chief Executive of UK Research integrity Office (UKRIO).
UKRIO is an independent charity, offering support to the public, researchers and organisations to further good practice in academic, scientific and medical research. They promote integrity and high ethical standards in research, as well as robust and fair methods to address poor practice and misconduct. They pursue these aims through their publications on research practice, in-depth support and services for research employers, their education and training activities, and by providing expert guidance in response to requests for assistance from individuals and organisations.
Established in 2006, their aims are to:
- Promote the good governance, management and conduct of academic, scientific and medical research.
- Share good practice on how to address poor practice, misconduct and unethical behaviour.
- Give confidential, independent and expert advice on specific research projects, cases, problems and issues.
James directs UKRIO’s work programme and leads its advisory service, responding to queries and concerns about research practice from researchers and the public.
Join us online or in person on Monday 16 May 2022 at 10.30 am.
You can register your place here via Eventbrite.
Integrity week 16 – 20 May 2022
Research Integrity – Researchers’ Responsibilities










BU PhD student attending HIV conference on scholarship
ESRC SWDTP – Applications open for PhD Studentships for September 2026
New paper by CMWH PhD student
Further CMWH contributions to 2026 ICM congress
ECR Funding Open Call: Research Culture & Community Grant – Apply Now
MSCA Postdoctoral Fellowships 2025 Call
ERC Advanced Grant 2025 Webinar
Horizon Europe Work Programme 2025 Published
Horizon Europe 2025 Work Programme pre-Published
Update on UKRO services
European research project exploring use of ‘virtual twins’ to better manage metabolic associated fatty liver disease